SAFit2 ameliorates paclitaxel-induced neuropathic pain by reducing spinal gliosis and elevating pro-resolving lipid mediators

BACKGROUND: Chemotherapy-induced neuropathic pain (CIPN) describes a pathological pain state that occurs dose-dependently as a side effect and can limit or even impede an effective cancer therapy. Unfortunately, current treatment possibilities for CIPN are remarkably confined and mostly inadequate a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wedel, Saskia, Hahnefeld, Lisa, Schreiber, Yannick, Namendorf, Christian, Heymann, Tim, Uhr, Manfred, Schmidt, Mathias V., de Bruin, Natasja, Hausch, Felix, Thomas, Dominique, Geisslinger, Gerd, Sisignano, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290418/
https://www.ncbi.nlm.nih.gov/pubmed/37355700
http://dx.doi.org/10.1186/s12974-023-02835-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290418/
https://www.ncbi.nlm.nih.gov/pubmed/37355700
http://dx.doi.org/10.1186/s12974-023-02835-5

Ejemplares similares